Database Update: Pharmaceutical Drug Import to Russia (July 2017)
Between January and July 2017, Russia imported 329.6 bln RUB worth of pharmaceutical drugs (free circulation prices, VAT included.) Ready-made drugs account for 281.2 bln RUB, with an 8.1% increase. The in-bulk import has fallen by 24.2% (48.4 bln RUB). The total import has risen by only 1.8%.
In July, the import followed the season’s trends, with a 3.8% and 20.6% decline in the import of ready-made and in-bulk drugs, respectively.
In physical terms, the import of ready-made drugs has increased by 6.8%, with 1.1 bln units. However, if calculated in minimum dosage units (MDU), the import of ready-made drugs in physical terms has fallen by 4.1%, with 20.1 bln MDUs. The in-bulk import has risen by 5.5% in physical terms, with 2.4 bln MDUs. The total import has fallen by 3.1%, though.
Most pharmaceutical drugs, imported to Russia between January and July 2017, were manufactured in Germany (22% of the import in monetary terms). Russia imported from 68 countries, with Turkey having made the best progress by doubling its import (0.6% of the import). The Netherlands and Switzerland have shown the worst dynamics, with a 22% and 21% decrease, respectively.
Read more about pharmaceutical drug import to Russia (June performance) here: http://rncph.com/news/17_07_2017
Dynamics of import of pharmaceuticals, including homeopathic and seawater drugs, to Russia, free circulation prices including customs clearance and VAT, RUB (January 2016 – July 2017)